FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell, Inc. (Nasdaq:OMCL), a leading healthcare technology provider focused on empowering autonomous medication management, will release its financial results ...
(NASDAQ:OMCL) (“Omnicell” or the “Company”), a leading healthcare technology provider focused on empowering autonomous medication management, today announced that Nnamdi Njoku has been appointed ...
Newly established role strengthens understanding of healthcare clinician needs to help shape the Company’s innovation priorities and portfolio decisions In this newly created position, Couldry will ...
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell, Inc. (NASDAQ: OMCL) (“Omnicell”) today announced the pricing of $150.0 million aggregate principal amount of 1.00% Convertible Senior Notes due 2029 (the ...
Healthcare tech company Omnicell (NASDAQ:OMCL) reported Q1 CY2026 results exceeding the market’s revenue expectations, with sales up 14.9% year on year to $309.9 million. Guidance for next quarter’s ...
Newly established role strengthens understanding of healthcare clinician needs to help shape the Company’s innovation priorities and portfolio decisions Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell” or the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results